Promoting STatin Adherence with a Tailored INtervention (STATIN)

  • Research type

    Research Study

  • Full title

    Promoting STatin Adherence with a Tailored INtervention (STATIN)

  • IRAS ID

    324941

  • Contact name

    Gaby Judah

  • Contact email

    g.judah@imperial.ac.uk

  • Sponsor organisation

    Imperial College London

  • Duration of Study in the UK

    1 years, 3 months, 28 days

  • Research summary

    Background

    Statins lower 'bad' cholesterol and stop or slow down heart disease. Taking statins as prescribed lowers the risk of heart attack, strokes, and other causes of death. However, 40-60% of patients stop taking statins one year after being prescribed.

    This research will use behavioural science to help understand why different people and groups do or don't take their statins to design a solution that can help many people adhere to their statin medications according to their specific needs.

    Aim: to develop a scalable intervention that can be individually tailored, using behavioural science to improve statin adherence.

    Design and methods:

    Phase 1 - identifying why people don't take statins: We will conduct 15 to 17 interviews to explore patients’ barriers to taking their statins as prescribed.

    Phase 2 - co-designing a tailored yet scalable way to help people take their statins: We will run six workshops with different people, mainly from groups less likely to take prescribed statins. In these workshops, we will decide on the best solution and discuss how to adapt it for different people.

    Patient and Public Involvement
    Three diverse public partners will join the steering committee and contribute to all aspects of the research. We will include people with different experiences and backgrounds and people who are less likely to take prescribed statins.

    Dissemination
    Findings will be shared through academic journals, national and international conferences, forums, and social media. The intervention will be subsequently tested and evaluated in a trial.

  • REC name

    North East - York Research Ethics Committee

  • REC reference

    23/NE/0192

  • Date of REC Opinion

    7 Nov 2023

  • REC opinion

    Further Information Favourable Opinion